Is Tempus AI Stock a Buy After Its 75% Rally? Here's What to Know as the Firm's Legal Chief Files a Trade
Polovin's sale of 30,075 shares was non-discretionary and tied to tax withholding from RSU vesting.
Tempus AI, Inc. (NASDAQ:TEM), a healthcare technology firm based in Chicago with a market capitalization of $10.7 billion and 3,800 employees, has experienced a remarkable 75% rally in its stock price. However, the company's legal chief, Andrew Polovin, has recently sold 30,075 shares of the stock, totaling $1.5 million, according to an SEC Form 4 filing.
The transaction value is based on a weighted average sale price of $51.29, while the post-transaction value is $61.25, based on the August 19 market close. Despite its impressive market valuation, Tempus AI remains unprofitable on a trailing twelve-month (TTM) basis, with a negative net income of $254.4 million, as it continues to invest in platform expansion and market penetration.
Investors should carefully weigh the potential risks and rewards before considering this stock a buy.
Brief written by urgent.news from Motley Fool's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
